FDA Pauses Minor Tanning-Bed Restrictions to Reassess Rulemaking
The FDA has withdrawn its 2015 proposal to restrict tanning bed sales and use by minors after more than 8,000 public comments, indicating it will study alternatives and potential unintended consequences before possibly restarting rulemaking. The move drew pushback from dermatology groups emphasizing the melanoma risk associated with UV exposure in youth, while noting prior steps in 2014 requiring warning labels and premarket review for sunlamp products.